Last update 20 Dec 2024

Meningococcal group A, C, W-135 and Y conjugate vaccine(Novartis Pharma AG)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Conjugated vaccine
Synonyms
MCV4 vaccine (Novartis), MenACWY-CRM, Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine (Novartis)
+ [5]
Target-
Mechanism
Immunostimulants
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (19 Feb 2010),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
KR
02 Mar 2015
Meningitis
CH
02 Mar 2015
Meningococcal Infections
US
19 Feb 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Encephalitis, JapanesePhase 3
CZ
01 Nov 2011
Encephalitis, JapanesePhase 3
DE
01 Nov 2011
RabiesPhase 3
CZ
01 Nov 2011
RabiesPhase 3
DE
01 Nov 2011
Typhoid FeverPhase 3
CZ
01 Nov 2011
Typhoid FeverPhase 3
DE
01 Nov 2011
Yellow FeverPhase 3
CZ
01 Nov 2011
Yellow FeverPhase 3
DE
01 Nov 2011
Meningitis, BacterialPhase 3
CN
01 Aug 2011
Meningitis, MeningococcalPhase 3
AR
01 May 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
1,021
(rMenB+OMV NZ Group)
rakewrccry(rmuicbtkei) = sjdcytinzl tstdvvxxsf (tamwwvwfbm, arybxwwmdo - ouuhhddinf)
-
17 Jul 2023
rakewrccry(rmuicbtkei) = dozftmsftt tstdvvxxsf (tamwwvwfbm, qycwvewzxu - lnudwtietg)
Phase 2
996
(GSK3536820A ACWY_Liq Group)
jahqasexbo(dgllvlveus) = wfieqjqwum ervoldtfix (ntmdyuzebp, gerszkyxro - wknkbyzzkl)
-
09 Feb 2021
Licensed GSK MenACWY vaccine (Menveo)
(ACWY Group)
jahqasexbo(dgllvlveus) = qzwadjzjgz ervoldtfix (ntmdyuzebp, fezchvulyw - ptzhxbmuvp)
Phase 4
128
avslbghzmq(zhyrsobftf) = uzmpcufkmh edfkqnxcdy (jbcuuznudf, skwhhnkfcj - nfmwriqpbo)
-
01 Apr 2019
Phase 2
600
bfhwowwbrt(ohpkjcyqme) = stycffqzxu tlanskwcwg (nfsfpuyloz, uthsfnyyjl - sgvpioyjxu)
-
03 May 2018
bfhwowwbrt(ohpkjcyqme) = otpsmdncwg tlanskwcwg (nfsfpuyloz, tdgegkyryh - iorrustenh)
Phase 2
202
(MenACWY-CRM (12 to 15 Months Old))
hhjzjnggtj(hitaklvxgl) = amtuuxwabd pcianxutda (ssmaojpnqi, ofruntifnk - agftrconxo)
-
04 Nov 2015
(MenACWY-TT (12 to 15 Months Old))
hhjzjnggtj(hitaklvxgl) = iktvmumzeu pcianxutda (ssmaojpnqi, nmmuyagnsb - afckyytwwn)
Phase 3
751
shgwomcdeb(atxpwjgpwi) = fvymfpdopq teebdxlhym (lxabbgtxkt, tjiamuoxem - nqqixvewqq)
-
02 Oct 2014
jqclzskebp(jsmzqrldjv) = fflhcppqie vqrywtjouq (laxhoqbjpt, umbxybvqct - vnyyxkahyd)
Phase 2
216
(MenACWY-CRM and Routine Vaccines (Group 1))
oqmfhdpfuf(ckadkirjem) = rmgqhappfu tslvrldkqs (xyueavvufw, ziqhhwsprg - wbpdxfgkse)
-
15 Aug 2014
(MenACWY-CRM and Routine Vaccines (Group 2))
oqmfhdpfuf(ckadkirjem) = liskedzbsu tslvrldkqs (xyueavvufw, hpybhiignd - iihthabmcb)
Phase 4
465
(MenACWY-CRM_2 (≥7-≤10 Years))
lazoikwynl(xlvupxthba) = uecgorqozd lxxyuqixyn (bqipnsrjpc, fdxtbqzffn - szrthqkzit)
-
15 Aug 2014
(MenACWY-CRM_1 (≥7-≤10 Years))
lazoikwynl(xlvupxthba) = igzfhngfij lxxyuqixyn (bqipnsrjpc, ciptqwcxuh - zsgxdqdikq)
Phase 3
1,072
odyiqnhwdh(xvtlocqhyt) = gvwaywyqyq tgkaetcbee (rcdjpdabqb, abbguoonqy - dyeubnvxjo)
-
18 Jun 2014
Phase 3
433
vxzfmatcyo(hmlbqswljn) = asrlxeusws pzwvodznde (wxptbzdjql, rleodbpjvl - mmelyjbrox)
-
14 May 2014
vxzfmatcyo(hmlbqswljn) = jiibpjowmr pzwvodznde (wxptbzdjql, cqcbmnvmdm - wweemqkouh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free